Revisitando a "epistemologia social": esboço de uma ecologia sociotécnica do trabalho intelectual

Formulado em 1952 pelos pesquisadores e bibliotecários americanos Margaret Egan e Jesse Shera, o conceito de 'Epistemologia Social', que propunha o estudo da produção, do fluxo e do consumo de qualquer tipo de "produto intelectual", teve pouca repercussão e baixa receptividade na literatura especializada da época. Retomando o conceito e relacionando-o a idéias e teorias concebidas por autores contemporâneos como Foucault, Lévy e Latour, o presente trabalho sugere que a 'Epistemologia Social' pode ser entendida como o estudo das relações recíprocas que se estabelecem entre os seres humanos e seu mutante entorno social, cultural e tecnológico, visando à atividade cognitiva, isto é, o ciclo que envolve a produção, a circulação e o uso do conhecimento, caracterizado em sua materialidade como uma ecologia sociotécnica do trabalho intelectual. Assim articulado, tal arcabouço conceitual poderia ser utilizado pela Ciência da Informação como embasamento teórico interessante e pertinente para as pesquisas científicas que a área desenvolve.

Sobre la fundamentación de la definición Aristotélica del tiempo en la del movimiento

El estudio aristotélico del tiempo (Phys. IV, 10-14), centrado en su definición del mismo como "número del movimiento según el antes y el después", presenta una sorprendente ausencia: en él no halla aplicación, como cabría esperar, la definición previamente dada del movimiento como "acto de la potencia en cuianto tal". Sin embargo, se muestra que la epistemología aristotélica permitiría esperar una (al aplicación. Asimismo, para mostrar quedicha aplicación sería posible, se ofrece una prueba, partiendo de la definición de movimiento, del teorema "lo que se mueve, se mueve de algo a algo", básico para la defiinición del tiempo como número del movimiento.

A novel population of human melanoma-specific CD8 T cells recognizes Melan-AMART-1 immunodominant nonapeptide but not the corresponding decapeptide.

HLA-A2-restricted cytolytic T cells specific for the immunodominant human tumor Ag Melan-A(MART-1) can kill most HLA-matched melanoma cells, through recognition of two naturally occurring antigenic variants, i.e., Melan-A nonamer AAGIGILTV and decamer EAAGIGILTV peptides. Several previous studies have suggested a high degree of TCR cross-reactivity to the two peptides. In this study, we describe for the first time that some T cell clones are exclusively nonamer specific, because they are not labeled by A2/decamer-tetramers and do not recognize the decamer when presented endogenously. Functional assays with peptides gave misleading results, possibly because decamers were cleaved by exopeptidases. Interestingly, nonapeptide-specific T cell clones were rarely Valpha2.1 positive (only 1 of 19 clones), in contrast to the known strong bias for Valpha2.1-positive TCRs found in decamer-specific clones (59 of 69 clones). Molecular modeling revealed that nonapeptide-specific TCRs formed unfavorable interactions with the decapeptide, whereas decapeptide-specific TCRs productively created a hydrogen bond between CDR1alpha and glutamic acid (E) of the decapeptide. Ex vivo analysis of T cells from melanoma metastases demonstrated that both nonamer and decamer-specific T cells were enriched to substantial frequencies in vivo, and representative clones showed efficient tumor cell recognition and killing. We conclude that the two peptides should be regarded as distinct epitopes when analyzing tumor immunity and developing immunotherapy against melanoma.

Final antigenic Melan-A peptides produced directly by the proteasomes are preferentially selected for presentation by HLA-A*0201 in melanoma cells.

The melanoma-associated protein Melan-A contains the immunodominant CTL epitope Melan-A(26/27-35)/HLA-A*0201 against which a high frequency of T lymphocytes has been detected in many melanoma patients. In this study we show that the in vitro degradation of a polypeptide encompassing Melan-A(26/27-35) by proteasomes produces both the final antigenic peptide and N-terminally extended intermediates. When human melanoma cells expressing the corresponding fragments were exposed to specific CTL, those expressing the minimal antigenic sequence were recognized more efficiently than those expressing the N-terminally extended intermediates. Using a tumor-reactive CTL clone, we confirmed that the recognition of melanoma cells expressing an N-terminally extended intermediate of Melan-A is inefficient. We demonstrated that the inefficient cytosolic trimming of N-terminally extended intermediates could offer a selective advantage for the preferred presentation of Melan-A peptides directly produced by the proteasomes. These results imply that both the proteasomes and postproteasomal peptidases limit the availability of antigenic peptides and that the efficiency of presentation may be affected by conditions that alter the ratio between fully and partially processed proteasomal products.

Proteasomal cleavage does not determine immunogenicity of gp100-derived peptides gp100 209-217 and gp100 209-217T210M.

Immune responses against tumor-associated antigens rely on efficient epitope presentation. The melanoma-associated antigen (Ag) gp100 contains HLA-A*0201 ligands that are characterized by low to medium binding affinity, among which gp100(209-217) is the most prominent (Kawakami et al., J Immunol 154:3961-3968, 1995). While this epitope is a natural T-cell target, it primes with low-efficiency T-cell responses during immunization. A modified gp100 epitope, gp100(209-217T210M), that contains a Thr to Met substitution at position 2 of the antigenic nonamer is characterized by high binding affinity for HLA-A*0201 and elicits strong and clinically effective T-cell responses. This higher affinity is believed to represent the sole reason for enhanced immunogenicity. Contrasting with this observation is the unpredictable relationship between affinity and immunogenicity observed in other antigen systems. In addition, we noted a striking difference between the capability of endogenously processed gp100(209-217) and gp100(209-217T210M) to induce T-cell responses in an in vitro model. Therefore, we questioned whether factors other than HLA-affinity might play a role in determining the immunogenicity of these epitopes. In the present study, we evaluated the in vitro proteasomal cleavages of 23meric precursor peptides encompassing the native sequence (gp100(201-223)) or the modified sequence (gp100(201-223T210M)). Here we show that the standard proteasome liberates the C-termini of both antigenic peptides but not the N-termini. Quantitative analysis of the digestion products revealed that more of the fragments displaying the final C-termini were produced from the wild-type precursor. However, a stronger TCR engagement was observed when fractions of digested gp100(201-223T210M) were used to activate an HLA-A*0201-expressing target T-cell clone. This difference was also found using separately produced, synthetic nonamers. In conclusion, the high binding affinity of gp100(209-217T210M) seems to compensate for possible differences in proteasomal cleavage at the biological level. Since the final antigenic nonamer is not directly produced by the proteasome, additional further factors may influence the antigenic peptide availability, such as post-proteasomal processing and intracellular peptide transport.

Reconeixement de punts clau en imatges mitjançant l'algorisme Random Ferns

Treball final de carrera basat en el reconeixement de punts clau en imatges mitjançant l'algorisme Random Ferns.

La Babele in cui viviamo. Traduzioni, riscritture, culture

Secondo Ludwig Wittgenstein occorre accettare come ovvia l'inconfrontabilità, e non la confrontabilità. E i due termini del confronto possibile o impossibile sono innanzi tutto le lingue. La traduzione svolge dunque una funzione decisiva nella vita del linguaggio. Nella traduzione le lingue si scambiano (e rubano) significati, rompono chiusura e provincialismo e comunicano la propria specifica forza significante. Silvana Borutti e Ute Heidmann riflettono sulla traduzione come esperienza di conoscenza, modello di rapporto tra lingue, letterature e culture, accesso conoscitivo, comunicativo e affettivo alla differenza. Si tratti di un testo o di un intero sistema simbolico, l'alterità non è mai un'entità data, bensì una forma dinamica che solo quando esce da sé riesce a misurare la complessità della propria relazione originaria di appartenenza e a realizzare il proprio potenziale di senso. Tradurre è allora un'operazione innovativa di attraversamento, trasmissione e metamorfosi. Per la vivibilità stessa del mondo, siamo sempre intenti a farlo: al limite, traduciamo noi a noi stessi, atto necessario per uscire dal narcisismo primario che ci trattiene in un orizzonte limitato e immediato.

Breast cancer suppressor candidate-1 (BCSC-1) is a melanoma tumor suppressor that down regulates MITF.

Understanding the molecular aberrations involved in the development and progression of metastatic melanoma (MM) is essential for a better diagnosis and targeted therapy. We identified breast cancer suppressor candidate-1 (BCSC-1) as a novel tumor suppressor in melanoma. BCSC-1 expression is decreased in human MM, and its ectopic expression in MM-derived cell lines blocks tumor formation in vivo and melanoma cell proliferation in vitro while increasing cell migration. We demonstrate that BCSC-1 binds to Sox10, which down regulates MITF, and results in a switch of melanoma cells from a proliferative to a migratory phenotype. In conclusion, we have identified BCSC-1 as a tumor suppressor in melanoma and as a novel regulator of the MITF pathway.